The proliferation and popularity of additional treatments in IVF, also known as add-ons, has generated widespread discussion and controversy in the UK, where concerns have addressed the lack of evidence to support the efficacy and safety of these treatments, their cost, and their connection to a wider context of privatisation of fertility treatment. Drawing on 42 interviews with IVF patients, this article explores the role of hope in the appeal of add-ons from the patient perspective. The analysis is presented in two parts: firstly, we investigate the role of hope in patients’ decision-making on treatment, contextualising add-ons in the broader trajectory of their IVF experience; secondly, we examine how patients navigate the offer of add-ons, focusing on the role of hope in how they rationalise their decisions on whether to include them in their fertility treatment. Our analysis shows how patients craft their hope to navigate the increasing number of available options in their quest to find the treatment(s) that will “work” for them. We suggest that the imperative for patients to explore all options is intensified with the emergence of add-ons, which produces a novel context and version of a “hope technology”.

体外受精中额外治疗（也称为附加治疗）的扩散和普及在英国引起了广泛的讨论和争议，英国担心缺乏证据来支持这些治疗的有效性和安全性、它们的成本和它们的有效性。与更广泛的生育治疗私有化背景的联系。本文利用对 IVF 患者的 42 次采访，从患者的角度探讨了希望在附加组件吸引力中的作用。分析分为两部分：首先，我们调查希望在患者治疗决策中的作用，将附加内容置于更广泛的试管婴儿体验轨迹中；其次，我们检查患者如何浏览附加组件的报价，关注希望在他们如何合理化决定是否将他们纳入生育治疗中的作用。我们的分析表明，患者在寻找对他们“有效”的治疗方法的过程中，如何在越来越多的可用选项中找到希望。我们建议，随着附加组件的出现，患者探索所有选择的必要性得到加强，这产生了“希望技术”的新背景和版本。